ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
62,906.11
0.03%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Immupharma Plc (IMM)

  7. Immupharma Plc (IMM) Noticias

IMM

Immupharma (IMM)

Immupharma Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:IMM
FechaHoraFuenteTítuloSímboloCompañía
03/05/202401:00RNS Regulatory NewsImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
24/04/202401:12RNS Non-RegulatoryImmupharma PLC IMMUPHARMA AT BIO-EQUITY 2024 12-14 MayLSE:IMMImmupharma Plc
19/04/202401:00RNS Regulatory NewsImmupharma PLC Grant of Share OptionsLSE:IMMImmupharma Plc
02/04/202406:52Alliance NewsAlliance NewsImmupharma jumps amid new IP strategy for P140 technology platformLSE:IMMImmupharma Plc
02/04/202401:03RNS Regulatory NewsImmupharma PLC New intellectual property strategy initiatedLSE:IMMImmupharma Plc
25/03/202407:20Alliance NewsAlliance NewsIncanthera says first order from skincare deal doublesLSE:IMMImmupharma Plc
25/03/202402:25RNS Regulatory NewsImmupharma PLC Incanthera provides Comm'l Update/Revenue F'castsLSE:IMMImmupharma Plc
14/03/202402:00RNS Non-RegulatoryImmupharma PLC IMMUPHARMA AT BIO-EUROPE SPRING 2024LSE:IMMImmupharma Plc
06/03/202407:05Alliance NewsAlliance NewsEARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue upLSE:IMMImmupharma Plc
06/03/202401:00RNS Regulatory NewsImmupharma PLC Financial, Business and Portfolio Develop't UpdateLSE:IMMImmupharma Plc
19/12/202311:52Alliance NewsAlliance NewsEARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrowsLSE:IMMImmupharma Plc
19/12/202301:00UK RegulatoryImmupharma PLC Simbec-Orion appointed as CROLSE:IMMImmupharma Plc
18/12/202301:15UK RegulatoryImmupharma PLC Incanthera - Comm'l Skincare Deal/GBP1M FundraiseLSE:IMMImmupharma Plc
07/09/202311:07Alliance NewsAlliance NewsTRADING UPDATES: RA International loss narrows as revenue growsLSE:IMMImmupharma Plc
07/09/202301:00UK RegulatoryImmupharma PLC Result of Retail Offer and Director ShareholdingLSE:IMMImmupharma Plc
31/08/202307:05Alliance NewsAlliance NewsImmuPharma launches GBP2 million fund raise as interim loss narrowsLSE:IMMImmupharma Plc
31/08/202301:02UK RegulatoryImmupharma PLC WRAP Retail Offer for up to GBP0.5mLSE:IMMImmupharma Plc
31/08/202301:01UK RegulatoryImmupharma PLC Subscription to raise GBP1.35m; Sharing Agr, RPTLSE:IMMImmupharma Plc
31/08/202301:00UK RegulatoryImmupharma PLC Interim resultsLSE:IMMImmupharma Plc
21/08/202301:00UK RegulatoryImmupharma PLC Extension of warrants in Incanthera plcLSE:IMMImmupharma Plc
11/08/202306:04UK RegulatoryImmupharma PLC Directorate ChangeLSE:IMMImmupharma Plc
30/06/202307:12UK RegulatoryImmupharma PLC Result of AGMLSE:IMMImmupharma Plc
19/06/202306:02Alliance NewsAlliance NewsIN BRIEF: ImmuPharma to start next two phases of Lupuzor trialLSE:IMMImmupharma Plc
19/06/202301:00UK RegulatoryImmupharma PLC Lupuzor UpdateLSE:IMMImmupharma Plc
06/06/202301:00UK RegulatoryImmupharma PLC IMM RNS Posting of RA and Notice of AGM 30 June 23LSE:IMMImmupharma Plc
18/05/202306:12Alliance NewsAlliance NewsIN BRIEF: ImmuPharma rises on FDA feedback for neurological diseaseLSE:IMMImmupharma Plc
18/05/202304:38Dow Jones NewsImmuPharma Shares Rise on Positive Guidance From US FDA for P140LSE:IMMImmupharma Plc
18/05/202301:00UK RegulatoryImmupharma PLC Positive Pre-IND meeting with FDALSE:IMMImmupharma Plc
11/05/202305:48Alliance NewsAlliance NewsIN BRIEF: ImmuPharma annual loss narrows as R&D spending reducedLSE:IMMImmupharma Plc
11/05/202301:00UK RegulatoryImmupharma PLC Final ResultsLSE:IMMImmupharma Plc
 Showing the most relevant articles for your search:LSE:IMM

Su Consulta Reciente

CCOM
US30
US 30
FX
USDMXN
US Dollar vs MXN
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
NYSE
AXP
American Express
NYSE
KO
Coca Cola
NYSE
MRK
Merck
COIN
SOLUSD
Solana
NYSE
VZ
Verizon Communications
COIN
ETHUSD
Ethereum
NYSE
XOM
Exxon Mobil
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados